Progression from cardiomyopathy to heart failure with reduced ejection fraction: A CORIN deficient course

Cardiomyopathies, encompassing hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM), constitute a diverse spectrum of heart muscle diseases that often culminating in heart failure (HF). The inherent molecular heterogeneity of these conditions has implications for prognosis and therapeu...

Full description

Saved in:
Bibliographic Details
Published inHeliyon Vol. 10; no. 18; p. e37838
Main Authors Kan, Jun-yan, Wang, Dong-chen, Jiang, Zi-hao, Wu, Li-da, Xu, Ke, Gu, Yue
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 30.09.2024
Elsevier
Subjects
Online AccessGet full text
ISSN2405-8440
2405-8440
DOI10.1016/j.heliyon.2024.e37838

Cover

Loading…
Abstract Cardiomyopathies, encompassing hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM), constitute a diverse spectrum of heart muscle diseases that often culminating in heart failure (HF). The inherent molecular heterogeneity of these conditions has implications for prognosis and therapeutic strategies. Publicly available microarray and RNA sequencing (RNA-seq) data sets of HCM (n = 106 from GSE36961) and DCM (n = 18 from GSE135055 and 166 from GSE141910) patients were employed for our analysis. The Non-negative Matrix Factorization (NMF) algorithm was applied to explore the molecular stratification within HCM and DCM, and enrichment analysis was performed to delineate their biological characteristics. By integrating bulk and single-nucleus RNA-seq (snRNA-seq) data, we identified a potential biomarker for HCM progression and cardiac fibrosis, which was subsequently validated using mendelian randomization and in vitro. Our application of NMF identified two distinct molecular clusters. Particularly, a profibrotic, heart failure with reduced ejection fraction (HFrEF)-resembling Cluster 1 emerged, characterized by diminished expression of CORIN and a high degree of fibroblast activation. This cluster also exhibited lower left ventricular ejection fraction (LVEF) and worse prognostic outcomes, establishing the significance of this molecular subclassification. We further found that overexpression of CORIN could mitigate TGFβ1-induced expression of col1a1 and α-SMA in neonatal rat cardiac fibroblasts. Our results indicated the heterogeneity of HCM population, and further evidenced the participation of corin in the progression of HCM, DCM and HFrEF. Nevertheless, our study is constrained by the lack of corresponding clinical data and experimental validation of the identified subtypes. Therefore, further studies are warranted to elucidate the downstream pathways of corin and to validate these findings in independent patient cohorts.
AbstractList Cardiomyopathies, encompassing hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM), constitute a diverse spectrum of heart muscle diseases that often culminating in heart failure (HF). The inherent molecular heterogeneity of these conditions has implications for prognosis and therapeutic strategies. Publicly available microarray and RNA sequencing (RNA-seq) data sets of HCM (n = 106 from GSE36961) and DCM (n = 18 from GSE135055 and 166 from GSE141910) patients were employed for our analysis. The Non-negative Matrix Factorization (NMF) algorithm was applied to explore the molecular stratification within HCM and DCM, and enrichment analysis was performed to delineate their biological characteristics. By integrating bulk and single-nucleus RNA-seq (snRNA-seq) data, we identified a potential biomarker for HCM progression and cardiac fibrosis, which was subsequently validated using mendelian randomization and in vitro. Our application of NMF identified two distinct molecular clusters. Particularly, a profibrotic, heart failure with reduced ejection fraction (HFrEF)-resembling Cluster 1 emerged, characterized by diminished expression of CORIN and a high degree of fibroblast activation. This cluster also exhibited lower left ventricular ejection fraction (LVEF) and worse prognostic outcomes, establishing the significance of this molecular subclassification. We further found that overexpression of CORIN could mitigate TGFβ1-induced expression of col1a1 and α-SMA in neonatal rat cardiac fibroblasts. Our results indicated the heterogeneity of HCM population, and further evidenced the participation of corin in the progression of HCM, DCM and HFrEF. Nevertheless, our study is constrained by the lack of corresponding clinical data and experimental validation of the identified subtypes. Therefore, further studies are warranted to elucidate the downstream pathways of corin and to validate these findings in independent patient cohorts.
Cardiomyopathies, encompassing hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM), constitute a diverse spectrum of heart muscle diseases that often culminating in heart failure (HF). The inherent molecular heterogeneity of these conditions has implications for prognosis and therapeutic strategies. Publicly available microarray and RNA sequencing (RNA-seq) data sets of HCM (n = 106 from GSE36961) and DCM (n = 18 from GSE135055 and 166 from GSE141910) patients were employed for our analysis. The Non-negative Matrix Factorization (NMF) algorithm was applied to explore the molecular stratification within HCM and DCM, and enrichment analysis was performed to delineate their biological characteristics. By integrating bulk and single-nucleus RNA-seq (snRNA-seq) data, we identified a potential biomarker for HCM progression and cardiac fibrosis, which was subsequently validated using mendelian randomization and in vitro. Our application of NMF identified two distinct molecular clusters. Particularly, a profibrotic, heart failure with reduced ejection fraction (HFrEF)-resembling Cluster 1 emerged, characterized by diminished expression of CORIN and a high degree of fibroblast activation. This cluster also exhibited lower left ventricular ejection fraction (LVEF) and worse prognostic outcomes, establishing the significance of this molecular subclassification. We further found that overexpression of CORIN could mitigate TGFβ1-induced expression of col1a1 and α-SMA in neonatal rat cardiac fibroblasts. Our results indicated the heterogeneity of HCM population, and further evidenced the participation of corin in the progression of HCM, DCM and HFrEF. Nevertheless, our study is constrained by the lack of corresponding clinical data and experimental validation of the identified subtypes. Therefore, further studies are warranted to elucidate the downstream pathways of corin and to validate these findings in independent patient cohorts.Cardiomyopathies, encompassing hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM), constitute a diverse spectrum of heart muscle diseases that often culminating in heart failure (HF). The inherent molecular heterogeneity of these conditions has implications for prognosis and therapeutic strategies. Publicly available microarray and RNA sequencing (RNA-seq) data sets of HCM (n = 106 from GSE36961) and DCM (n = 18 from GSE135055 and 166 from GSE141910) patients were employed for our analysis. The Non-negative Matrix Factorization (NMF) algorithm was applied to explore the molecular stratification within HCM and DCM, and enrichment analysis was performed to delineate their biological characteristics. By integrating bulk and single-nucleus RNA-seq (snRNA-seq) data, we identified a potential biomarker for HCM progression and cardiac fibrosis, which was subsequently validated using mendelian randomization and in vitro. Our application of NMF identified two distinct molecular clusters. Particularly, a profibrotic, heart failure with reduced ejection fraction (HFrEF)-resembling Cluster 1 emerged, characterized by diminished expression of CORIN and a high degree of fibroblast activation. This cluster also exhibited lower left ventricular ejection fraction (LVEF) and worse prognostic outcomes, establishing the significance of this molecular subclassification. We further found that overexpression of CORIN could mitigate TGFβ1-induced expression of col1a1 and α-SMA in neonatal rat cardiac fibroblasts. Our results indicated the heterogeneity of HCM population, and further evidenced the participation of corin in the progression of HCM, DCM and HFrEF. Nevertheless, our study is constrained by the lack of corresponding clinical data and experimental validation of the identified subtypes. Therefore, further studies are warranted to elucidate the downstream pathways of corin and to validate these findings in independent patient cohorts.
Cardiomyopathies, encompassing hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM), constitute a diverse spectrum of heart muscle diseases that often culminating in heart failure (HF). The inherent molecular heterogeneity of these conditions has implications for prognosis and therapeutic strategies.Publicly available microarray and RNA sequencing (RNA-seq) data sets of HCM (n = 106 from GSE36961) and DCM (n = 18 from GSE135055 and 166 from GSE141910) patients were employed for our analysis. The Non-negative Matrix Factorization (NMF) algorithm was applied to explore the molecular stratification within HCM and DCM, and enrichment analysis was performed to delineate their biological characteristics. By integrating bulk and single-nucleus RNA-seq (snRNA-seq) data, we identified a potential biomarker for HCM progression and cardiac fibrosis, which was subsequently validated using mendelian randomization and in vitro.Our application of NMF identified two distinct molecular clusters. Particularly, a profibrotic, heart failure with reduced ejection fraction (HFrEF)-resembling Cluster 1 emerged, characterized by diminished expression of CORIN and a high degree of fibroblast activation. This cluster also exhibited lower left ventricular ejection fraction (LVEF) and worse prognostic outcomes, establishing the significance of this molecular subclassification. We further found that overexpression of CORIN could mitigate TGFβ1-induced expression of col1a1 and α-SMA in neonatal rat cardiac fibroblasts.Our results indicated the heterogeneity of HCM population, and further evidenced the participation of corin in the progression of HCM, DCM and HFrEF. Nevertheless, our study is constrained by the lack of corresponding clinical data and experimental validation of the identified subtypes. Therefore, further studies are warranted to elucidate the downstream pathways of corin and to validate these findings in independent patient cohorts.
Cardiomyopathies, encompassing hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM), constitute a diverse spectrum of heart muscle diseases that often culminating in heart failure (HF). The inherent molecular heterogeneity of these conditions has implications for prognosis and therapeutic strategies. Publicly available microarray and RNA sequencing (RNA-seq) data sets of HCM (n = 106 from GSE36961) and DCM (n = 18 from GSE135055 and 166 from GSE141910) patients were employed for our analysis. The Non-negative Matrix Factorization (NMF) algorithm was applied to explore the molecular stratification within HCM and DCM, and enrichment analysis was performed to delineate their biological characteristics. By integrating bulk and single-nucleus RNA-seq (snRNA-seq) data, we identified a potential biomarker for HCM progression and cardiac fibrosis, which was subsequently validated using mendelian randomization and in vitro. Our application of NMF identified two distinct molecular clusters. Particularly, a profibrotic, heart failure with reduced ejection fraction (HFrEF)-resembling Cluster 1 emerged, characterized by diminished expression of CORIN and a high degree of fibroblast activation. This cluster also exhibited lower left ventricular ejection fraction (LVEF) and worse prognostic outcomes, establishing the significance of this molecular subclassification. We further found that overexpression of CORIN could mitigate TGFβ1-induced expression of col1a1 and α-SMA in neonatal rat cardiac fibroblasts. Our results indicated the heterogeneity of HCM population, and further evidenced the participation of corin in the progression of HCM, DCM and HFrEF. Nevertheless, our study is constrained by the lack of corresponding clinical data and experimental validation of the identified subtypes. Therefore, further studies are warranted to elucidate the downstream pathways of corin and to validate these findings in independent patient cohorts.
ArticleNumber e37838
Author Kan, Jun-yan
Gu, Yue
Xu, Ke
Wu, Li-da
Wang, Dong-chen
Jiang, Zi-hao
Author_xml – sequence: 1
  givenname: Jun-yan
  orcidid: 0000-0001-6838-8556
  surname: Kan
  fullname: Kan, Jun-yan
  email: kanjy98@126.com
– sequence: 2
  givenname: Dong-chen
  surname: Wang
  fullname: Wang, Dong-chen
  email: wdcmed1995@163.com
– sequence: 3
  givenname: Zi-hao
  surname: Jiang
  fullname: Jiang, Zi-hao
  email: jiangzihao357@163.com
– sequence: 4
  givenname: Li-da
  surname: Wu
  fullname: Wu, Li-da
  email: lidawunjmu@outlook.com
– sequence: 5
  givenname: Ke
  surname: Xu
  fullname: Xu, Ke
  email: xukehigh123@stu.njmu.edu.cn
– sequence: 6
  givenname: Yue
  surname: Gu
  fullname: Gu, Yue
  email: guyue_jessica@163.com
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39315128$$D View this record in MEDLINE/PubMed
BookMark eNqNUk1vEzEUtFARLaE_AeQjlwR_rr1cUBXxEamiCMHZ8tpvE0ebdbB3W-Xf43RDaU9w8pM9bzTjmZforI89IPSakgUltHq3XWygC4fYLxhhYgFcaa6foQsmiJxrIcjZo_kcXea8JYRQqata8RfonNecSsr0BQrfUlwnyDnEHrcp7rCzyYe4O8S9HTYHPES8AZsG3NrQjQnwXRg2OIEfHXgMW3DDtGrvh_f4Ci9vvq--Yg9tcAH6Abs4pgyv0PPWdhkuT-cM_fz08cfyy_z65vNqeXU9d5LKYc4crwC8tYJXtlYNr5Twsm1ULTSnDbha0VZLqnilldXMK68IcU1NWiZ8A3yGVhOvj3Zr9insbDqYaIO5v4hpbYqd4DowmkBV1gVroOx6pV0LvvJt7T2VxLHC9WHi2o_NDrwrbpLtnpA-fenDxqzjraFUUMWK4hl6e2JI8dcIeTC7kB10ne0hjtmUHASVda3Zf0CJVpVUdVWgbx7rehD0J9cCkBPApZhzgvYBQok5VshszalC5lghM1Xor2EoCd0GSCYfMyxRh1SSLl8Y_sHwG6Za028
Cites_doi 10.1038/s41586-022-04817-8
10.1038/s41421-022-00490-3
10.1093/cvr/cvaa023
10.1016/j.peptides.2018.05.012
10.1172/jci.insight.133782
10.1016/j.jacbts.2022.10.010
10.1093/bioinformatics/btm254
10.1111/joim.12944
10.1038/s41598-021-89451-6
10.1056/NEJMoa021332
10.1161/HYPERTENSIONAHA.115.06300
10.1016/j.mayocp.2020.04.028
10.1186/1471-2105-9-559
10.1056/NEJMoa1409077
10.1093/nar/gkv007
10.3390/ijms23020946
10.1016/j.jcmg.2020.11.006
10.1161/CIRCRESAHA.115.306565
10.1093/bioinformatics/bti623
10.1038/nmeth.3337
10.1073/pnas.0506580102
10.1016/j.yjmcc.2019.04.011
10.1038/s41467-021-21246-9
10.1186/1471-2105-11-367
10.1161/HYPERTENSIONAHA.112.193631
10.1136/heartjnl-2021-320729
10.1016/j.yexcr.2021.112552
10.1186/s12916-019-1469-4
10.1016/S0140-6736(21)01205-8
10.1073/pnas.150149097
10.1373/clinchem.2010.143883
10.1016/j.jacbts.2022.03.017
10.1038/s41419-022-05403-6
10.1016/j.pharmthera.2022.108185
10.1042/CS20110403
10.1161/CIRCULATIONAHA.121.056324
10.1161/CIRCRESAHA.118.313089
10.1161/CIRCULATIONAHA.120.050498
10.1161/CIRCHEARTFAILURE.109.895581
10.1085/jgp.202213204
10.1161/CIRCHEARTFAILURE.109.903849
10.1002/ehf2.12288
10.1186/1471-2105-12-77
10.1002/ejhf.1461
10.1001/jama.2020.10262
10.1093/bioinformatics/btx364
10.1038/s41587-021-01033-z
10.1038/s41587-021-01091-3
10.1093/nar/28.1.27
10.1161/CIRCRESAHA.117.309711
10.1016/j.jacc.2022.03.375
10.1161/01.CIR.92.4.785
ContentType Journal Article
Copyright 2024
2024 The Authors. Published by Elsevier Ltd.
2024 The Authors. Published by Elsevier Ltd. 2024
Copyright_xml – notice: 2024
– notice: 2024 The Authors. Published by Elsevier Ltd.
– notice: 2024 The Authors. Published by Elsevier Ltd. 2024
DBID 6I.
AAFTH
AAYXX
CITATION
NPM
7X8
7S9
L.6
5PM
DOA
DOI 10.1016/j.heliyon.2024.e37838
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
PubMed
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList
MEDLINE - Academic

PubMed
AGRICOLA

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2405-8440
ExternalDocumentID oai_doaj_org_article_80e67d742be24dd78cfed6df9dd150c2
PMC11417248
39315128
10_1016_j_heliyon_2024_e37838
S2405844024138698
Genre Journal Article
GroupedDBID 0R~
457
53G
5VS
6I.
AAEDW
AAFTH
AAFWJ
AALRI
AAYWO
ABMAC
ACGFS
ACLIJ
ACVFH
ADBBV
ADCNI
ADEZE
ADVLN
AEUPX
AEXQZ
AFJKZ
AFPKN
AFPUW
AFTJW
AGHFR
AIGII
AITUG
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
AOIJS
APXCP
BAWUL
BCNDV
DIK
EBS
FDB
GROUPED_DOAJ
HYE
KQ8
M~E
O9-
OK1
ROL
RPM
SSZ
AAYXX
CITATION
EJD
IPNFZ
RIG
0SF
AACTN
NCXOZ
NPM
7X8
7S9
L.6
5PM
ID FETCH-LOGICAL-c515t-2c36eedaa436a97b3674d5fb794831bec971f85173687a82d7d700cb90f24dbe3
IEDL.DBID DOA
ISSN 2405-8440
IngestDate Wed Aug 27 01:28:33 EDT 2025
Thu Aug 21 18:30:59 EDT 2025
Fri Aug 22 20:22:16 EDT 2025
Fri Jul 11 02:36:46 EDT 2025
Thu Jan 02 22:37:13 EST 2025
Thu Aug 21 00:27:49 EDT 2025
Sat Aug 30 17:17:39 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 18
Keywords Molecular subtypes
Heart failure with reduced ejection fraction
Cardiomyopathy
Bioinformatics
CORIN
Language English
License This is an open access article under the CC BY-NC license.
2024 The Authors. Published by Elsevier Ltd.
This is an open access article under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c515t-2c36eedaa436a97b3674d5fb794831bec971f85173687a82d7d700cb90f24dbe3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
These authors contributed equally to this work and share first authorship.
ORCID 0000-0001-6838-8556
OpenAccessLink https://doaj.org/article/80e67d742be24dd78cfed6df9dd150c2
PMID 39315128
PQID 3108765796
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_80e67d742be24dd78cfed6df9dd150c2
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11417248
proquest_miscellaneous_3154159982
proquest_miscellaneous_3108765796
pubmed_primary_39315128
crossref_primary_10_1016_j_heliyon_2024_e37838
elsevier_sciencedirect_doi_10_1016_j_heliyon_2024_e37838
PublicationCentury 2000
PublicationDate 2024-09-30
PublicationDateYYYYMMDD 2024-09-30
PublicationDate_xml – month: 09
  year: 2024
  text: 2024-09-30
  day: 30
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Heliyon
PublicationTitleAlternate Heliyon
PublicationYear 2024
Publisher Elsevier Ltd
Elsevier
Publisher_xml – name: Elsevier Ltd
– name: Elsevier
References Codden, Chin (bib11) 2022; 23
Wang, Ye, Kong, Chao, Yu, Jiang, Luo, Gu, Chen (bib37) 2021; 402
Liu, Yin, Chen, Chen, Li, Zhang, Sun, Yuan, Wang, Song, Wang, Hu, Zhou (bib48) 2023; 9
Sean, Meltzer (bib15) 2007; 23
Murphy, Ibrahim, Januzzi (bib6) 2020; 324
Hahn, Knutsdottir, Luo, Bedi, Margulies, Haldar, Stolina, Yin, Khakoo, Vaishnav, Bader, Kass, Sharma (bib10) 2021; 143
Helms, Tang, O'Leary, Friedline, Wauchope, Arora, Wasserman, Smith, Lee, Wen, Shavit, Liu, Previs, Day (bib14) 2020; 5
Vakrou, Liu, Zhu, Greenland, Simsek, Hebl, Guan, Woldemichael, Talbot, Aon, Fukunaga, Abraham (bib45) 2021; 11
Zou, Ouyang, Lin, Zhang, Yang, Pang, Han, Tang (bib53) 2022; 13
Maron, Gardin, Flack, Gidding, Kurosaki, Bild (bib4) 1995; 92
Ibebuogu, Gladysheva, Houng, Reed (bib59) 2011; 4
Conway, Lex, Gehlenborg (bib26) 2017; 33
Nauffal, Di Achille, Klarqvist, Cunningham, Pirruccello, Weng, Morrill, Choi, Khurshid, Friedman, Nekoui, Roselli, Ng, Philippakis, Batra, Ellinor, Lubitz (bib35) 2021; 55
Sing, Sander, Beerenwinkel, Lengauer (bib28) 2005; 21
Hua, Wang, Jia, Xiong, Hu, Chang, Lai, Xu, Zhao, Song (bib9) 2020; 18
Hua, Wang, Jia, Xiong, Hu, Chang, Lai, Xu, Zhao, Song (bib19) 2020; 18
Nakagawa, Nishikimi, Kuwahara (bib56) 2019; 111
Sun, Guan, Moran, Wu, Qian, Schedin, Dai, Danilov, Alumkal, Adey, Spellman, Xia (bib32) 2022; 40
Ritchie, Phipson, Wu, Hu, Law, Shi, Smyth (bib16) 2015; 43
Jin, Guerrero-Juarez, Zhang, Chang, Ramos, Kuan, Myung, Plikus, Nie (bib33) 2021; 12
McKenna, Maron, Thiene (bib5) 2017; 121
Jassal, Matthews, Viteri, Gong, Lorente, Fabregat, Sidiropoulos, Cook, Gillespie, Haw, Loney, May, Milacic, Rothfels, Sevilla, Shamovsky, Shorser, Varusai, Weiser, Wu, Stein, Hermjakob, D'Eustachio (bib20) 2020; 48
McMurray, Packer, Desai, Gong, Lefkowitz, Rizkala, Rouleau, Shi, Solomon, Swedberg, Zile (bib55) 2014; 371
Gladysheva, Wang, McNamee, Houng, Mohamad, Fan, Reed (bib63) 2013; 61
Schwartz, Gjini, Gopal, Fetterman (bib50) 2022; 7
Wu, Hu, Xu, Chen, Guo, Dai, Feng, Zhou, Tang, Zhan, Fu, Liu, Bo, Yu (bib24) 2021; 2
Newman, Liu, Green, Gentles, Feng, Xu, Hoang, Diehn, Alizadeh (bib30) 2015; 12
Chaffin, Papangeli, Simonson, Akkad, Hill, Arduini, Fleming, Melanson, Hayat, Kost-Alimova, Atwa, Ye, Bedi, Nahrendorf, Kaushik, Stegmann, Margulies, Tucker, Ellinor (bib18) 2022; 608
Bernardi, Burns, Toffoli, Pickering, Sakoda, Tsorotes, Grixti, Velkoska, Burrell, Johnston, Thomas, Fabris, Tikellis (bib46) 2012; 123
Tripathi, Wang, Sullivan, Fan, Gladysheva, Reed (bib60) 2016; 67
Yan, Wu, Morser, Wu (bib57) 2000; 97
Bos, Hebl, Oberg, Sun, Herman, Teekakirikul, Seidman, Seidman, dos Remedios, Maleszewski, V Schaff, Dearani, Noseworthy, Friedman, Ommen, V Brozovich, Ackerman (bib8) 2020; 95
Semenov, Tamm, Seferian, Postnikov, Karpova, Serebryanaya, Koshkina, Krasnoselsky, Katrukha (bib62) 2010; 56
Camici, Tschöpe, Di Carli, Rimoldi, Van Linthout (bib51) 2020; 116
Dann, Henderson, Teichmann, Morgan, Marioni (bib31) 2022; 40
Reichart, Magnussen, Zeller, Blankenberg (bib2) 2019; 286
Maron, Rowin, Casey, Link, Lesser, Chan, Garberich, Udelson, Maron (bib39) 2015
Meng, Bhandary, Bhuiyan, James, Osinska, Valiente-Alandi, Shay-Winkler, Gulick, Molkentin, Blaxall, Robbins (bib54) 2018; 123
Zhang, Gu, Zhang, Dong, Wu (bib61) 2022; 11
Langfelder, Horvath (bib25) 2008; 9
Chaffin, Papangeli, Simonson, Akkad, Hill, Arduini, Fleming, Melanson, Hayat, Kost-Alimova, Atwa, Ye, Bedi, Nahrendorf, Kaushik, Stegmann, Margulies, Tucker, Ellinor (bib12) 2022; 608
Codden, Chin (bib17) 2022; 23
Subramanian, Tamayo, Mootha, Mukherjee, Ebert, Gillette, Paulovich, Pomeroy, Golub, Lander, Mesirov (bib22) 2005; 102
Liang, Raita, Hasegawa, Fifer, Maurer, Reilly, Shimada (bib42) 2022
Kanehisa, Goto (bib23) 2000; 28
Maron, Olivotto, Betocchi, Casey, Lesser, Losi, Cecchi, Maron (bib41) 2003; 348
Tsutsui (bib7) 2022; 238
Bos, Hebl, Oberg, Sun, Herman, Teekakirikul, Seidman, Seidman, dos Remedios, Maleszewski, Schaff, Dearani, Noseworthy, Friedman, Ommen, Brozovich, Ackerman (bib47) 2020; 95
De Lange, Farrell, Hernandez, Stempien, Kreitzer, Jacobs, Petty, Moss, Crone, Ralphe (bib34) 2023; 155
Zuo, Ren, Ge, Luo, Ye, Wang, Wu, Chao, Gu, Gao, Ge, Bin Gao, Hu, Zhang, Chen (bib36) 2019; 130
Hahn, Knutsdottir, Luo, Bedi, Margulies, Haldar, Stolina, Yin, Khakoo, Vaishnav, Bader, Kass, Sharma (bib29) 2021; 143
Ommen, Semsarian (bib1) 2021; 398
Robin, Turck, Hainard, Tiberti, Lisacek, Sanchez, Müller (bib27) 2011; 12
Tayal, Verdonschot, Hazebroek, Howard, Gregson, Newsome, Gulati, Pua, Halliday, Lota, Buchan, Whiffin, Kanapeckaite, Baruah, Jarman, O'Regan, Barton, Ware, Pennell, Adriaans, Bekkers, Donovan, Frenneaux, Cooper, Januzzi, Cleland, Cook, Deo, Heymans, Prasad (bib43) 2022; 79
Mandawat, Chattranukulchai, Mandawat, Blood, Ambati, Hayes, Rehwald, Kim, Heitner, Shah, Klem (bib49) 2021; 14
Dong, Chen, Yang, He, Liu, Zheng, Li, Zhou, Ruan, Plow, Wu (bib58) 2010; 3
Tripathi, Sullivan, Fan, Houng, Mehta, Reed, Gladysheva (bib64) 2020; 21
Seferović, Polovina, Bauersachs, Arad, Ben Gal, Lund, Felix, Arbustini, Caforio, Farmakis, Filippatos, Gialafos, Kanjuh, Krljanac, Limongelli, Linhart, Lyon, Maksimović, Miličić, Milinković, Noutsias, Oto, Oto, Pavlović, Piepoli, Ristić, Rosano, Seggewiss, Ašanin, Seferović, Ruschitzka, Čelutkiene, Jaarsma, Mueller, Moura, Hill, Volterrani, Lopatin, Metra, Backs, Mullens, Chioncel, de Boer, Anker, Rapezzi, Coats, Tschöpe (bib38) 2019; 21
Verdonschot, Wang, Derks, Adriaens, Stroeks, Henkens, Raafs, Sikking, de Koning, van den Wijngaard, Krapels, Nabben, Brunner, Heymans (bib44) 2023; 8
Travers, Kamal, Robbins, Yutzey, Blaxall (bib52) 2016; 118
Gaujoux, Seoighe (bib21) 2010; 11
Kissopoulou, Trinks, Green, Karlsson, Jonasson, Gunnarsson (bib40) 2018; 5
Daniels, Fusi, Semsarian, Naidu (bib3) 2021; 144
De Lange, Farrell, Hernandez, Stempien, Kreitzer, Jacobs, Petty, Moss, Crone, Ralphe (bib13) 2023; 155
Liu (10.1016/j.heliyon.2024.e37838_bib48) 2023; 9
Tripathi (10.1016/j.heliyon.2024.e37838_bib64) 2020; 21
Ritchie (10.1016/j.heliyon.2024.e37838_bib16) 2015; 43
McMurray (10.1016/j.heliyon.2024.e37838_bib55) 2014; 371
Hua (10.1016/j.heliyon.2024.e37838_bib9) 2020; 18
Vakrou (10.1016/j.heliyon.2024.e37838_bib45) 2021; 11
Dann (10.1016/j.heliyon.2024.e37838_bib31) 2022; 40
Robin (10.1016/j.heliyon.2024.e37838_bib27) 2011; 12
Sun (10.1016/j.heliyon.2024.e37838_bib32) 2022; 40
Daniels (10.1016/j.heliyon.2024.e37838_bib3) 2021; 144
Hahn (10.1016/j.heliyon.2024.e37838_bib29) 2021; 143
Bernardi (10.1016/j.heliyon.2024.e37838_bib46) 2012; 123
Nauffal (10.1016/j.heliyon.2024.e37838_bib35) 2021; 55
Reichart (10.1016/j.heliyon.2024.e37838_bib2) 2019; 286
Zhang (10.1016/j.heliyon.2024.e37838_bib61) 2022; 11
Zuo (10.1016/j.heliyon.2024.e37838_bib36) 2019; 130
Tripathi (10.1016/j.heliyon.2024.e37838_bib60) 2016; 67
Newman (10.1016/j.heliyon.2024.e37838_bib30) 2015; 12
Gaujoux (10.1016/j.heliyon.2024.e37838_bib21) 2010; 11
Zou (10.1016/j.heliyon.2024.e37838_bib53) 2022; 13
Verdonschot (10.1016/j.heliyon.2024.e37838_bib44) 2023; 8
Travers (10.1016/j.heliyon.2024.e37838_bib52) 2016; 118
Ibebuogu (10.1016/j.heliyon.2024.e37838_bib59) 2011; 4
Mandawat (10.1016/j.heliyon.2024.e37838_bib49) 2021; 14
De Lange (10.1016/j.heliyon.2024.e37838_bib13) 2023; 155
Tayal (10.1016/j.heliyon.2024.e37838_bib43) 2022; 79
Semenov (10.1016/j.heliyon.2024.e37838_bib62) 2010; 56
Bos (10.1016/j.heliyon.2024.e37838_bib8) 2020; 95
Sean (10.1016/j.heliyon.2024.e37838_bib15) 2007; 23
Nakagawa (10.1016/j.heliyon.2024.e37838_bib56) 2019; 111
Gladysheva (10.1016/j.heliyon.2024.e37838_bib63) 2013; 61
Chaffin (10.1016/j.heliyon.2024.e37838_bib18) 2022; 608
Schwartz (10.1016/j.heliyon.2024.e37838_bib50) 2022; 7
Murphy (10.1016/j.heliyon.2024.e37838_bib6) 2020; 324
Codden (10.1016/j.heliyon.2024.e37838_bib17) 2022; 23
Wu (10.1016/j.heliyon.2024.e37838_bib24) 2021; 2
Maron (10.1016/j.heliyon.2024.e37838_bib41) 2003; 348
Wang (10.1016/j.heliyon.2024.e37838_bib37) 2021; 402
Maron (10.1016/j.heliyon.2024.e37838_bib39) 2015
Camici (10.1016/j.heliyon.2024.e37838_bib51) 2020; 116
Hua (10.1016/j.heliyon.2024.e37838_bib19) 2020; 18
Conway (10.1016/j.heliyon.2024.e37838_bib26) 2017; 33
Jassal (10.1016/j.heliyon.2024.e37838_bib20) 2020; 48
Ommen (10.1016/j.heliyon.2024.e37838_bib1) 2021; 398
Meng (10.1016/j.heliyon.2024.e37838_bib54) 2018; 123
De Lange (10.1016/j.heliyon.2024.e37838_bib34) 2023; 155
Jin (10.1016/j.heliyon.2024.e37838_bib33) 2021; 12
Dong (10.1016/j.heliyon.2024.e37838_bib58) 2010; 3
Langfelder (10.1016/j.heliyon.2024.e37838_bib25) 2008; 9
Seferović (10.1016/j.heliyon.2024.e37838_bib38) 2019; 21
Hahn (10.1016/j.heliyon.2024.e37838_bib10) 2021; 143
Kissopoulou (10.1016/j.heliyon.2024.e37838_bib40) 2018; 5
McKenna (10.1016/j.heliyon.2024.e37838_bib5) 2017; 121
Liang (10.1016/j.heliyon.2024.e37838_bib42) 2022
Helms (10.1016/j.heliyon.2024.e37838_bib14) 2020; 5
Yan (10.1016/j.heliyon.2024.e37838_bib57) 2000; 97
Maron (10.1016/j.heliyon.2024.e37838_bib4) 1995; 92
Codden (10.1016/j.heliyon.2024.e37838_bib11) 2022; 23
Subramanian (10.1016/j.heliyon.2024.e37838_bib22) 2005; 102
Sing (10.1016/j.heliyon.2024.e37838_bib28) 2005; 21
Chaffin (10.1016/j.heliyon.2024.e37838_bib12) 2022; 608
Bos (10.1016/j.heliyon.2024.e37838_bib47) 2020; 95
Tsutsui (10.1016/j.heliyon.2024.e37838_bib7) 2022; 238
Kanehisa (10.1016/j.heliyon.2024.e37838_bib23) 2000; 28
References_xml – volume: 398
  start-page: 2102
  year: 2021
  end-page: 2108
  ident: bib1
  article-title: Hypertrophic cardiomyopathy: a practical approach to guideline directed management
  publication-title: Lancet
– volume: 143
  start-page: 120
  year: 2021
  end-page: 134
  ident: bib29
  article-title: Myocardial gene expression signatures in human heart failure with preserved ejection fraction
  publication-title: Circulation
– volume: 55
  year: 2021
  ident: bib35
  article-title: Genetics of myocardial interstitial fibrosis in the human heart and association with disease
  publication-title: medRxiv
– volume: 21
  start-page: 553
  year: 2019
  end-page: 576
  ident: bib38
  article-title: Heart failure in cardiomyopathies: a position paper from the heart failure association of the European society of cardiology
  publication-title: Eur. J. Heart Fail.
– volume: 40
  start-page: 527
  year: 2022
  end-page: 538
  ident: bib32
  article-title: Identifying phenotype-associated subpopulations by integrating bulk and single-cell sequencing data
  publication-title: Nat. Biotechnol.
– volume: 92
  start-page: 785
  year: 1995
  end-page: 789
  ident: bib4
  article-title: Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in the CARDIA study
  publication-title: Circulation
– volume: 43
  start-page: e47
  year: 2015
  ident: bib16
  article-title: Limma powers differential expression analyses for RNA-sequencing and microarray studies
  publication-title: Nucleic Acids Res.
– volume: 102
  start-page: 15545
  year: 2005
  end-page: 15550
  ident: bib22
  article-title: Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles
  publication-title: Proc. Natl. Acad. Sci. USA
– volume: 28
  start-page: 27
  year: 2000
  end-page: 30
  ident: bib23
  article-title: KEGG: kyoto encyclopedia of genes and genomes
  publication-title: Nucleic Acids Res.
– volume: 123
  start-page: 29
  year: 2012
  end-page: 37
  ident: bib46
  article-title: Angiotensin-converting enzyme 2 regulates renal atrial natriuretic peptide through angiotensin-(1-7)
  publication-title: Clin Sci
– volume: 324
  start-page: 488
  year: 2020
  end-page: 504
  ident: bib6
  article-title: Heart failure with reduced ejection fraction: a review
  publication-title: JAMA, J. Am. Med. Assoc.
– volume: 12
  start-page: 453
  year: 2015
  end-page: 457
  ident: bib30
  article-title: Robust enumeration of cell subsets from tissue expression profiles
  publication-title: Nat. Methods
– volume: 143
  start-page: 120
  year: 2021
  end-page: 134
  ident: bib10
  article-title: Myocardial gene expression signatures in human heart failure with preserved ejection fraction
  publication-title: Circulation
– volume: 14
  start-page: 1338
  year: 2021
  end-page: 1350
  ident: bib49
  article-title: Progression of myocardial fibrosis in nonischemic DCM and association with mortality and heart failure outcomes
  publication-title: JACC Cardiovasc Imaging
– volume: 12
  start-page: 77
  year: 2011
  ident: bib27
  article-title: pROC: an open-source package for R and S+ to analyze and compare ROC curves
  publication-title: BMC Bioinf.
– volume: 111
  start-page: 18
  year: 2019
  end-page: 25
  ident: bib56
  article-title: Atrial and brain natriuretic peptides: hormones secreted from the heart
  publication-title: Peptides (N.Y.)
– volume: 21
  start-page: 3940
  year: 2005
  end-page: 3941
  ident: bib28
  article-title: ROCR: visualizing classifier performance in R
  publication-title: Bioinformatics
– volume: 5
  start-page: 716
  year: 2018
  end-page: 723
  ident: bib40
  article-title: Homozygous missense MYBPC3 Pro873His mutation associated with increased risk for heart failure development in hypertrophic cardiomyopathy
  publication-title: ESC Heart Fail
– volume: 608
  start-page: 174
  year: 2022
  end-page: 180
  ident: bib18
  article-title: Single-nucleus profiling of human dilated and hypertrophic cardiomyopathy
  publication-title: Nature
– volume: 118
  start-page: 1021
  year: 2016
  end-page: 1040
  ident: bib52
  article-title: Cardiac fibrosis: the fibroblast awakens
  publication-title: Circ. Res.
– volume: 8
  start-page: 406
  year: 2023
  end-page: 418
  ident: bib44
  article-title: Clustering of cardiac transcriptome profiles reveals unique: subgroups of dilated cardiomyopathy patients
  publication-title: JACC Basic Transl Sci
– volume: 155
  year: 2023
  ident: bib13
  article-title: cMyBP-C ablation in human engineered cardiac tissue causes progressive Ca2+-handling abnormalities
  publication-title: J. Gen. Physiol.
– volume: 7
  start-page: 1161
  year: 2022
  end-page: 1179
  ident: bib50
  article-title: Inefficient batteries in heart failure: metabolic bottlenecks disrupting the mitochondrial ecosystem
  publication-title: JACC Basic Transl Sci
– volume: 121
  start-page: 722
  year: 2017
  end-page: 730
  ident: bib5
  article-title: Classification, epidemiology, and global burden of cardiomyopathies
  publication-title: Circ. Res.
– volume: 12
  start-page: 1
  year: 2021
  end-page: 20
  ident: bib33
  article-title: Inference and analysis of cell-cell communication using CellChat
  publication-title: Nat. Commun.
– volume: 11
  year: 2010
  ident: bib21
  article-title: A flexible R package for nonnegative matrix factorization
  publication-title: BMC Bioinf.
– volume: 56
  start-page: 1166
  year: 2010
  end-page: 1176
  ident: bib62
  article-title: Processing of pro-B-type natriuretic peptide: furin and corin as candidate convertases
  publication-title: Clin. Chem.
– volume: 11
  start-page: 1
  year: 2022
  end-page: 15
  ident: bib61
  article-title: Corin: a key mediator in sodium homeostasis, vascular remodeling, and heart failure
  publication-title: Biology
– volume: 23
  year: 2022
  ident: bib17
  article-title: Common and distinctive intercellular communication patterns in human obstructive and nonobstructive hypertrophic cardiomyopathy
  publication-title: Int. J. Mol. Sci.
– volume: 23
  year: 2022
  ident: bib11
  article-title: Common and distinctive intercellular communication patterns in human obstructive and nonobstructive hypertrophic cardiomyopathy
  publication-title: Int. J. Mol. Sci.
– volume: 130
  start-page: 170
  year: 2019
  end-page: 183
  ident: bib36
  article-title: Activation of the PP2A catalytic subunit by ivabradine attenuates the development of diabetic cardiomyopathy
  publication-title: J. Mol. Cell. Cardiol.
– volume: 371
  start-page: 993
  year: 2014
  end-page: 1004
  ident: bib55
  article-title: Angiotensin–neprilysin inhibition versus enalapril in heart failure
  publication-title: N. Engl. J. Med.
– volume: 4
  start-page: 114
  year: 2011
  end-page: 120
  ident: bib59
  article-title: Decompensated heart failure is associated with reduced corin levels and decreased cleavage of pro-atrial natriuretic peptide
  publication-title: Circ Heart Fail
– volume: 33
  start-page: 2938
  year: 2017
  end-page: 2940
  ident: bib26
  article-title: UpSetR: an R package for the visualization of intersecting sets and their properties
  publication-title: Bioinformatics
– year: 2022
  ident: bib42
  article-title: Proteomics profiling reveals a distinct high-risk molecular subtype of hypertrophic cardiomyopathy
  publication-title: Heart
– volume: 3
  start-page: 207
  year: 2010
  end-page: 211
  ident: bib58
  article-title: Plasma Soluble Corin in patients with heart failure
  publication-title: Circ Heart Fail
– volume: 238
  year: 2022
  ident: bib7
  article-title: Recent advances in the pharmacological therapy of chronic heart failure: evidence and guidelines
  publication-title: Pharmacol. Ther.
– volume: 18
  start-page: 1
  year: 2020
  end-page: 16
  ident: bib19
  article-title: Multi-level transcriptome sequencing identifies COL1A1 as a candidate marker in human heart failure progression
  publication-title: BMC Med.
– volume: 18
  start-page: 1
  year: 2020
  end-page: 16
  ident: bib9
  article-title: Multi-level transcriptome sequencing identifies COL1A1 as a candidate marker in human heart failure progression
  publication-title: BMC Med.
– volume: 21
  year: 2020
  ident: bib64
  article-title: Cardiac-specific overexpression of catalytically inactive corin reduces edema, contractile dysfunction, and death in mice with dilated cardiomyopathy
  publication-title: Int. J. Mol. Sci.
– volume: 23
  start-page: 1846
  year: 2007
  end-page: 1847
  ident: bib15
  article-title: GEOquery: a bridge between the gene expression Omnibus (GEO) and BioConductor
  publication-title: Bioinformatics
– volume: 13
  start-page: 1
  year: 2022
  end-page: 10
  ident: bib53
  article-title: MYBPC3 deficiency in cardiac fibroblasts drives their activation and contributes to fibrosis
  publication-title: Cell Death Dis.
– volume: 95
  start-page: 1354
  year: 2020
  end-page: 1368
  ident: bib8
  article-title: Marked up-regulation of ACE2 in hearts of patients with obstructive hypertrophic cardiomyopathy: implications for SARS-CoV-2–mediated COVID-19
  publication-title: Mayo Clin. Proc.
– volume: 40
  start-page: 245
  year: 2022
  end-page: 253
  ident: bib31
  article-title: Differential abundance testing on single-cell data using k-nearest neighbor graphs
  publication-title: Nat. Biotechnol.
– year: 2015
  ident: bib39
  article-title: Hypertrophic Cardiomyopathy in Adulthood Associated with Low Cardiovascular Mortality with Contemporary Management Strategies
– volume: 79
  start-page: 2219
  year: 2022
  end-page: 2232
  ident: bib43
  article-title: Precision phenotyping of dilated cardiomyopathy using multidimensional data
  publication-title: J. Am. Coll. Cardiol.
– volume: 155
  year: 2023
  ident: bib34
  article-title: cMyBP-C ablation in human engineered cardiac tissue causes progressive Ca2+-handling abnormalities
  publication-title: J. Gen. Physiol.
– volume: 95
  start-page: 1354
  year: 2020
  end-page: 1368
  ident: bib47
  article-title: Marked up-regulation of ACE2 in hearts of patients with obstructive hypertrophic cardiomyopathy: implications for SARS-CoV-2–mediated COVID-19
  publication-title: Mayo Clin. Proc.
– volume: 2
  year: 2021
  ident: bib24
  article-title: clusterProfiler 4.0: a universal enrichment tool for interpreting omics data
  publication-title: Innovation
– volume: 97
  start-page: 8525
  year: 2000
  end-page: 8529
  ident: bib57
  article-title: Corin, a transmembrane cardiac serine protease, acts as a pro-atrial natriuretic peptide-converting enzyme
  publication-title: Proc Natl Acad Sci U S A
– volume: 116
  start-page: 806
  year: 2020
  end-page: 816
  ident: bib51
  article-title: Coronary microvascular dysfunction in hypertrophy and heart failure
  publication-title: Cardiovasc. Res.
– volume: 608
  start-page: 174
  year: 2022
  end-page: 180
  ident: bib12
  article-title: Single-nucleus profiling of human dilated and hypertrophic cardiomyopathy
  publication-title: Nature
– volume: 402
  year: 2021
  ident: bib37
  article-title: Mitoferrin 2 deficiency prevents mitochondrial iron overload-induced endothelial injury and alleviates atherosclerosis
  publication-title: Exp. Cell Res.
– volume: 5
  year: 2020
  ident: bib14
  article-title: Effects of MYBPC3 loss-of-function mutations preceding hypertrophic cardiomyopathy
  publication-title: JCI Insight
– volume: 11
  start-page: 1
  year: 2021
  end-page: 19
  ident: bib45
  article-title: Differences in molecular phenotype in mouse and human hypertrophic cardiomyopathy
  publication-title: Sci. Rep.
– volume: 9
  year: 2008
  ident: bib25
  article-title: WGCNA: an R package for weighted correlation network analysis
  publication-title: BMC Bioinf.
– volume: 144
  start-page: 759
  year: 2021
  end-page: 762
  ident: bib3
  article-title: Myosin modulation in hypertrophic cardiomyopathy and systolic heart failure: getting inside the engine
  publication-title: Circulation
– volume: 9
  year: 2023
  ident: bib48
  article-title: Lineage-specific regulatory changes in hypertrophic cardiomyopathy unraveled by single-nucleus RNA-seq and spatial transcriptomics
  publication-title: Cell Discov
– volume: 123
  start-page: 1285
  year: 2018
  end-page: 1297
  ident: bib54
  article-title: Myofibroblast-specific TGFβ receptor II signaling in the fibrotic response to cardiac myosin binding protein C-induced cardiomyopathy
  publication-title: Circ. Res.
– volume: 286
  start-page: 362
  year: 2019
  end-page: 372
  ident: bib2
  article-title: Dilated cardiomyopathy: from epidemiologic to genetic phenotypes: a translational review of current literature
  publication-title: J. Intern. Med.
– volume: 61
  start-page: 327
  year: 2013
  end-page: 332
  ident: bib63
  article-title: Corin overexpression improves cardiac function, heart failure, and survival in mice with dilated cardiomyopathy
  publication-title: Hypertension
– volume: 348
  start-page: 295
  year: 2003
  end-page: 303
  ident: bib41
  article-title: Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy
  publication-title: N. Engl. J. Med.
– volume: 67
  start-page: 362
  year: 2016
  end-page: 367
  ident: bib60
  article-title: Depressed corin levels indicate early systolic dysfunction before increases of atrial natriuretic peptide/B-type natriuretic peptide and heart failure development
  publication-title: Hypertension
– volume: 48
  start-page: D498
  year: 2020
  end-page: D503
  ident: bib20
  article-title: The reactome pathway knowledgebase
  publication-title: Nucleic Acids Res.
– volume: 608
  start-page: 174
  year: 2022
  ident: 10.1016/j.heliyon.2024.e37838_bib18
  article-title: Single-nucleus profiling of human dilated and hypertrophic cardiomyopathy
  publication-title: Nature
  doi: 10.1038/s41586-022-04817-8
– volume: 9
  year: 2023
  ident: 10.1016/j.heliyon.2024.e37838_bib48
  article-title: Lineage-specific regulatory changes in hypertrophic cardiomyopathy unraveled by single-nucleus RNA-seq and spatial transcriptomics
  publication-title: Cell Discov
  doi: 10.1038/s41421-022-00490-3
– volume: 116
  start-page: 806
  year: 2020
  ident: 10.1016/j.heliyon.2024.e37838_bib51
  article-title: Coronary microvascular dysfunction in hypertrophy and heart failure
  publication-title: Cardiovasc. Res.
  doi: 10.1093/cvr/cvaa023
– volume: 111
  start-page: 18
  year: 2019
  ident: 10.1016/j.heliyon.2024.e37838_bib56
  article-title: Atrial and brain natriuretic peptides: hormones secreted from the heart
  publication-title: Peptides (N.Y.)
  doi: 10.1016/j.peptides.2018.05.012
– volume: 5
  year: 2020
  ident: 10.1016/j.heliyon.2024.e37838_bib14
  article-title: Effects of MYBPC3 loss-of-function mutations preceding hypertrophic cardiomyopathy
  publication-title: JCI Insight
  doi: 10.1172/jci.insight.133782
– volume: 8
  start-page: 406
  year: 2023
  ident: 10.1016/j.heliyon.2024.e37838_bib44
  article-title: Clustering of cardiac transcriptome profiles reveals unique: subgroups of dilated cardiomyopathy patients
  publication-title: JACC Basic Transl Sci
  doi: 10.1016/j.jacbts.2022.10.010
– volume: 608
  start-page: 174
  year: 2022
  ident: 10.1016/j.heliyon.2024.e37838_bib12
  article-title: Single-nucleus profiling of human dilated and hypertrophic cardiomyopathy
  publication-title: Nature
  doi: 10.1038/s41586-022-04817-8
– volume: 23
  start-page: 1846
  year: 2007
  ident: 10.1016/j.heliyon.2024.e37838_bib15
  article-title: GEOquery: a bridge between the gene expression Omnibus (GEO) and BioConductor
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btm254
– volume: 286
  start-page: 362
  year: 2019
  ident: 10.1016/j.heliyon.2024.e37838_bib2
  article-title: Dilated cardiomyopathy: from epidemiologic to genetic phenotypes: a translational review of current literature
  publication-title: J. Intern. Med.
  doi: 10.1111/joim.12944
– volume: 11
  start-page: 1
  year: 2021
  ident: 10.1016/j.heliyon.2024.e37838_bib45
  article-title: Differences in molecular phenotype in mouse and human hypertrophic cardiomyopathy
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-021-89451-6
– volume: 348
  start-page: 295
  year: 2003
  ident: 10.1016/j.heliyon.2024.e37838_bib41
  article-title: Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa021332
– volume: 67
  start-page: 362
  year: 2016
  ident: 10.1016/j.heliyon.2024.e37838_bib60
  article-title: Depressed corin levels indicate early systolic dysfunction before increases of atrial natriuretic peptide/B-type natriuretic peptide and heart failure development
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.115.06300
– volume: 95
  start-page: 1354
  year: 2020
  ident: 10.1016/j.heliyon.2024.e37838_bib47
  article-title: Marked up-regulation of ACE2 in hearts of patients with obstructive hypertrophic cardiomyopathy: implications for SARS-CoV-2–mediated COVID-19
  publication-title: Mayo Clin. Proc.
  doi: 10.1016/j.mayocp.2020.04.028
– volume: 9
  year: 2008
  ident: 10.1016/j.heliyon.2024.e37838_bib25
  article-title: WGCNA: an R package for weighted correlation network analysis
  publication-title: BMC Bioinf.
  doi: 10.1186/1471-2105-9-559
– volume: 371
  start-page: 993
  year: 2014
  ident: 10.1016/j.heliyon.2024.e37838_bib55
  article-title: Angiotensin–neprilysin inhibition versus enalapril in heart failure
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1409077
– volume: 43
  start-page: e47
  year: 2015
  ident: 10.1016/j.heliyon.2024.e37838_bib16
  article-title: Limma powers differential expression analyses for RNA-sequencing and microarray studies
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkv007
– volume: 23
  year: 2022
  ident: 10.1016/j.heliyon.2024.e37838_bib17
  article-title: Common and distinctive intercellular communication patterns in human obstructive and nonobstructive hypertrophic cardiomyopathy
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms23020946
– volume: 14
  start-page: 1338
  year: 2021
  ident: 10.1016/j.heliyon.2024.e37838_bib49
  article-title: Progression of myocardial fibrosis in nonischemic DCM and association with mortality and heart failure outcomes
  publication-title: JACC Cardiovasc Imaging
  doi: 10.1016/j.jcmg.2020.11.006
– volume: 118
  start-page: 1021
  year: 2016
  ident: 10.1016/j.heliyon.2024.e37838_bib52
  article-title: Cardiac fibrosis: the fibroblast awakens
  publication-title: Circ. Res.
  doi: 10.1161/CIRCRESAHA.115.306565
– volume: 21
  start-page: 3940
  year: 2005
  ident: 10.1016/j.heliyon.2024.e37838_bib28
  article-title: ROCR: visualizing classifier performance in R
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/bti623
– volume: 12
  start-page: 453
  year: 2015
  ident: 10.1016/j.heliyon.2024.e37838_bib30
  article-title: Robust enumeration of cell subsets from tissue expression profiles
  publication-title: Nat. Methods
  doi: 10.1038/nmeth.3337
– volume: 102
  start-page: 15545
  year: 2005
  ident: 10.1016/j.heliyon.2024.e37838_bib22
  article-title: Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.0506580102
– volume: 130
  start-page: 170
  year: 2019
  ident: 10.1016/j.heliyon.2024.e37838_bib36
  article-title: Activation of the PP2A catalytic subunit by ivabradine attenuates the development of diabetic cardiomyopathy
  publication-title: J. Mol. Cell. Cardiol.
  doi: 10.1016/j.yjmcc.2019.04.011
– volume: 12
  start-page: 1
  year: 2021
  ident: 10.1016/j.heliyon.2024.e37838_bib33
  article-title: Inference and analysis of cell-cell communication using CellChat
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-021-21246-9
– volume: 11
  year: 2010
  ident: 10.1016/j.heliyon.2024.e37838_bib21
  article-title: A flexible R package for nonnegative matrix factorization
  publication-title: BMC Bioinf.
  doi: 10.1186/1471-2105-11-367
– volume: 61
  start-page: 327
  year: 2013
  ident: 10.1016/j.heliyon.2024.e37838_bib63
  article-title: Corin overexpression improves cardiac function, heart failure, and survival in mice with dilated cardiomyopathy
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.112.193631
– year: 2022
  ident: 10.1016/j.heliyon.2024.e37838_bib42
  article-title: Proteomics profiling reveals a distinct high-risk molecular subtype of hypertrophic cardiomyopathy
  publication-title: Heart
  doi: 10.1136/heartjnl-2021-320729
– volume: 402
  year: 2021
  ident: 10.1016/j.heliyon.2024.e37838_bib37
  article-title: Mitoferrin 2 deficiency prevents mitochondrial iron overload-induced endothelial injury and alleviates atherosclerosis
  publication-title: Exp. Cell Res.
  doi: 10.1016/j.yexcr.2021.112552
– volume: 18
  start-page: 1
  year: 2020
  ident: 10.1016/j.heliyon.2024.e37838_bib19
  article-title: Multi-level transcriptome sequencing identifies COL1A1 as a candidate marker in human heart failure progression
  publication-title: BMC Med.
  doi: 10.1186/s12916-019-1469-4
– volume: 398
  start-page: 2102
  year: 2021
  ident: 10.1016/j.heliyon.2024.e37838_bib1
  article-title: Hypertrophic cardiomyopathy: a practical approach to guideline directed management
  publication-title: Lancet
  doi: 10.1016/S0140-6736(21)01205-8
– volume: 97
  start-page: 8525
  year: 2000
  ident: 10.1016/j.heliyon.2024.e37838_bib57
  article-title: Corin, a transmembrane cardiac serine protease, acts as a pro-atrial natriuretic peptide-converting enzyme
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.150149097
– volume: 56
  start-page: 1166
  year: 2010
  ident: 10.1016/j.heliyon.2024.e37838_bib62
  article-title: Processing of pro-B-type natriuretic peptide: furin and corin as candidate convertases
  publication-title: Clin. Chem.
  doi: 10.1373/clinchem.2010.143883
– volume: 7
  start-page: 1161
  year: 2022
  ident: 10.1016/j.heliyon.2024.e37838_bib50
  article-title: Inefficient batteries in heart failure: metabolic bottlenecks disrupting the mitochondrial ecosystem
  publication-title: JACC Basic Transl Sci
  doi: 10.1016/j.jacbts.2022.03.017
– volume: 55
  year: 2021
  ident: 10.1016/j.heliyon.2024.e37838_bib35
  article-title: Genetics of myocardial interstitial fibrosis in the human heart and association with disease
  publication-title: medRxiv
– volume: 48
  start-page: D498
  year: 2020
  ident: 10.1016/j.heliyon.2024.e37838_bib20
  article-title: The reactome pathway knowledgebase
  publication-title: Nucleic Acids Res.
– volume: 95
  start-page: 1354
  year: 2020
  ident: 10.1016/j.heliyon.2024.e37838_bib8
  article-title: Marked up-regulation of ACE2 in hearts of patients with obstructive hypertrophic cardiomyopathy: implications for SARS-CoV-2–mediated COVID-19
  publication-title: Mayo Clin. Proc.
  doi: 10.1016/j.mayocp.2020.04.028
– volume: 13
  start-page: 1
  year: 2022
  ident: 10.1016/j.heliyon.2024.e37838_bib53
  article-title: MYBPC3 deficiency in cardiac fibroblasts drives their activation and contributes to fibrosis
  publication-title: Cell Death Dis.
  doi: 10.1038/s41419-022-05403-6
– volume: 238
  year: 2022
  ident: 10.1016/j.heliyon.2024.e37838_bib7
  article-title: Recent advances in the pharmacological therapy of chronic heart failure: evidence and guidelines
  publication-title: Pharmacol. Ther.
  doi: 10.1016/j.pharmthera.2022.108185
– volume: 123
  start-page: 29
  year: 2012
  ident: 10.1016/j.heliyon.2024.e37838_bib46
  article-title: Angiotensin-converting enzyme 2 regulates renal atrial natriuretic peptide through angiotensin-(1-7)
  publication-title: Clin Sci
  doi: 10.1042/CS20110403
– volume: 144
  start-page: 759
  year: 2021
  ident: 10.1016/j.heliyon.2024.e37838_bib3
  article-title: Myosin modulation in hypertrophic cardiomyopathy and systolic heart failure: getting inside the engine
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.121.056324
– volume: 123
  start-page: 1285
  year: 2018
  ident: 10.1016/j.heliyon.2024.e37838_bib54
  article-title: Myofibroblast-specific TGFβ receptor II signaling in the fibrotic response to cardiac myosin binding protein C-induced cardiomyopathy
  publication-title: Circ. Res.
  doi: 10.1161/CIRCRESAHA.118.313089
– volume: 143
  start-page: 120
  year: 2021
  ident: 10.1016/j.heliyon.2024.e37838_bib10
  article-title: Myocardial gene expression signatures in human heart failure with preserved ejection fraction
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.120.050498
– volume: 4
  start-page: 114
  year: 2011
  ident: 10.1016/j.heliyon.2024.e37838_bib59
  article-title: Decompensated heart failure is associated with reduced corin levels and decreased cleavage of pro-atrial natriuretic peptide
  publication-title: Circ Heart Fail
  doi: 10.1161/CIRCHEARTFAILURE.109.895581
– volume: 155
  year: 2023
  ident: 10.1016/j.heliyon.2024.e37838_bib34
  article-title: cMyBP-C ablation in human engineered cardiac tissue causes progressive Ca2+-handling abnormalities
  publication-title: J. Gen. Physiol.
  doi: 10.1085/jgp.202213204
– volume: 3
  start-page: 207
  year: 2010
  ident: 10.1016/j.heliyon.2024.e37838_bib58
  article-title: Plasma Soluble Corin in patients with heart failure
  publication-title: Circ Heart Fail
  doi: 10.1161/CIRCHEARTFAILURE.109.903849
– volume: 2
  year: 2021
  ident: 10.1016/j.heliyon.2024.e37838_bib24
  article-title: clusterProfiler 4.0: a universal enrichment tool for interpreting omics data
  publication-title: Innovation
– volume: 5
  start-page: 716
  year: 2018
  ident: 10.1016/j.heliyon.2024.e37838_bib40
  article-title: Homozygous missense MYBPC3 Pro873His mutation associated with increased risk for heart failure development in hypertrophic cardiomyopathy
  publication-title: ESC Heart Fail
  doi: 10.1002/ehf2.12288
– volume: 11
  start-page: 1
  year: 2022
  ident: 10.1016/j.heliyon.2024.e37838_bib61
  article-title: Corin: a key mediator in sodium homeostasis, vascular remodeling, and heart failure
  publication-title: Biology
– volume: 12
  start-page: 77
  year: 2011
  ident: 10.1016/j.heliyon.2024.e37838_bib27
  article-title: pROC: an open-source package for R and S+ to analyze and compare ROC curves
  publication-title: BMC Bioinf.
  doi: 10.1186/1471-2105-12-77
– volume: 143
  start-page: 120
  year: 2021
  ident: 10.1016/j.heliyon.2024.e37838_bib29
  article-title: Myocardial gene expression signatures in human heart failure with preserved ejection fraction
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.120.050498
– volume: 23
  year: 2022
  ident: 10.1016/j.heliyon.2024.e37838_bib11
  article-title: Common and distinctive intercellular communication patterns in human obstructive and nonobstructive hypertrophic cardiomyopathy
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms23020946
– volume: 155
  year: 2023
  ident: 10.1016/j.heliyon.2024.e37838_bib13
  article-title: cMyBP-C ablation in human engineered cardiac tissue causes progressive Ca2+-handling abnormalities
  publication-title: J. Gen. Physiol.
  doi: 10.1085/jgp.202213204
– volume: 21
  start-page: 553
  year: 2019
  ident: 10.1016/j.heliyon.2024.e37838_bib38
  article-title: Heart failure in cardiomyopathies: a position paper from the heart failure association of the European society of cardiology
  publication-title: Eur. J. Heart Fail.
  doi: 10.1002/ejhf.1461
– volume: 324
  start-page: 488
  year: 2020
  ident: 10.1016/j.heliyon.2024.e37838_bib6
  article-title: Heart failure with reduced ejection fraction: a review
  publication-title: JAMA, J. Am. Med. Assoc.
  doi: 10.1001/jama.2020.10262
– volume: 33
  start-page: 2938
  year: 2017
  ident: 10.1016/j.heliyon.2024.e37838_bib26
  article-title: UpSetR: an R package for the visualization of intersecting sets and their properties
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btx364
– volume: 40
  start-page: 245
  year: 2022
  ident: 10.1016/j.heliyon.2024.e37838_bib31
  article-title: Differential abundance testing on single-cell data using k-nearest neighbor graphs
  publication-title: Nat. Biotechnol.
  doi: 10.1038/s41587-021-01033-z
– volume: 40
  start-page: 527
  year: 2022
  ident: 10.1016/j.heliyon.2024.e37838_bib32
  article-title: Identifying phenotype-associated subpopulations by integrating bulk and single-cell sequencing data
  publication-title: Nat. Biotechnol.
  doi: 10.1038/s41587-021-01091-3
– volume: 28
  start-page: 27
  year: 2000
  ident: 10.1016/j.heliyon.2024.e37838_bib23
  article-title: KEGG: kyoto encyclopedia of genes and genomes
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/28.1.27
– volume: 121
  start-page: 722
  year: 2017
  ident: 10.1016/j.heliyon.2024.e37838_bib5
  article-title: Classification, epidemiology, and global burden of cardiomyopathies
  publication-title: Circ. Res.
  doi: 10.1161/CIRCRESAHA.117.309711
– volume: 79
  start-page: 2219
  year: 2022
  ident: 10.1016/j.heliyon.2024.e37838_bib43
  article-title: Precision phenotyping of dilated cardiomyopathy using multidimensional data
  publication-title: J. Am. Coll. Cardiol.
  doi: 10.1016/j.jacc.2022.03.375
– volume: 21
  year: 2020
  ident: 10.1016/j.heliyon.2024.e37838_bib64
  article-title: Cardiac-specific overexpression of catalytically inactive corin reduces edema, contractile dysfunction, and death in mice with dilated cardiomyopathy
  publication-title: Int. J. Mol. Sci.
– volume: 92
  start-page: 785
  year: 1995
  ident: 10.1016/j.heliyon.2024.e37838_bib4
  article-title: Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in the CARDIA study
  publication-title: Circulation
  doi: 10.1161/01.CIR.92.4.785
– volume: 18
  start-page: 1
  year: 2020
  ident: 10.1016/j.heliyon.2024.e37838_bib9
  article-title: Multi-level transcriptome sequencing identifies COL1A1 as a candidate marker in human heart failure progression
  publication-title: BMC Med.
  doi: 10.1186/s12916-019-1469-4
– year: 2015
  ident: 10.1016/j.heliyon.2024.e37838_bib39
SSID ssj0001586973
Score 2.2837553
Snippet Cardiomyopathies, encompassing hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM), constitute a diverse spectrum of heart muscle diseases that...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
elsevier
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage e37838
SubjectTerms algorithms
Bioinformatics
biomarkers
Cardiomyopathy
CORIN
fibroblasts
fibrosis
heart failure
Heart failure with reduced ejection fraction
microarray technology
Molecular subtypes
myocardium
patients
prognosis
rats
RNA
sequence analysis
therapeutics
Title Progression from cardiomyopathy to heart failure with reduced ejection fraction: A CORIN deficient course
URI https://dx.doi.org/10.1016/j.heliyon.2024.e37838
https://www.ncbi.nlm.nih.gov/pubmed/39315128
https://www.proquest.com/docview/3108765796
https://www.proquest.com/docview/3154159982
https://pubmed.ncbi.nlm.nih.gov/PMC11417248
https://doaj.org/article/80e67d742be24dd78cfed6df9dd150c2
Volume 10
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwELVQD4gLouVrKUVG4pptGju2w61UVAWJghCVerP8MVazKknVpof998zE2bILEr1w3U029sx450385pmxd8kJEUINReO8KqSOuKQwqxTeS6kNaaDByLY4VSdn8vN5fb521BdxwrI8cDbcvilB6YgFnIdKxqhNSBBVTE2MiGXC-O-LOW-tmMr9wUY1Wvxu2dlfzC_gsl32pHlayTkIbagnZS0ZjZr9Gznpb8z5J3VyLRcdP2GPJxDJD_Pgt9kD6HbYwy_TNvlT1n4j1lVW3ODUQMLDSDv9uezpBOIlH3pOJ1kPPLmWeOmcXsfya5JxhchhMfKz6Nbc9vCeH_Kjr98_nfIIpDiBo-KhJ_rHM3Z2_PHH0UkxnalQBEQuQ1EFoTAtOieFco32QmkZ6-RxWRpxgA5t9EFCFKaFMtqZKqLtyzL4pkxofg_iOdvq-g5eMp6iU75xWDIhiClr4xKUlXMgjQoBgp-x-cq49ipLZ9gVp2xhJ29Y8obN3pixD-SCu4tJ-Xr8AOPBTvFg74uHGTMrB9oJRGRwgD_V3vf8tyuHW1xktHPiOuhvbyxiYIxaatv91zU1giGsXnEIL3KQ3M1ENIKQFT7BbITPxlQ3v-nai1HsG-tVxJjSvPofxtllj2i-me_ymm0N17ewh6Bq8G_G9fMLOiclNA
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Progression+from+cardiomyopathy+to+heart+failure+with+reduced+ejection+fraction%3A+A+CORIN+deficient+course&rft.jtitle=Heliyon&rft.au=Kan%2C+Jun-yan&rft.au=Wang%2C+Dong-chen&rft.au=Jiang%2C+Zi-hao&rft.au=Wu%2C+Li-da&rft.date=2024-09-30&rft.issn=2405-8440&rft.eissn=2405-8440&rft.volume=10&rft.issue=18+p.e37838-&rft_id=info:doi/10.1016%2Fj.heliyon.2024.e37838&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2405-8440&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2405-8440&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2405-8440&client=summon